| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 06/04/2009 | WO2009069132A2 Novel reverse transcriptase inhibitors |
| 06/04/2009 | WO2009068170A2 2-(benzyl- and 1h-pyrazol-4-ylmethyl)sulfinyl thiazole derivatives as herbicides and plant growth regulators |
| 06/04/2009 | WO2009047798A3 Acetamide derivatives as glucokinase activators, their process and medicinal applications |
| 06/04/2009 | WO2009040331A3 Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologies |
| 06/04/2009 | US20090143592 Glucagon Antagonists/Inverse Agonists |
| 06/04/2009 | US20090143446 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof |
| 06/04/2009 | US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators |
| 06/04/2009 | US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors |
| 06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 06/04/2009 | US20090143358 Inhibitors of ion channels |
| 06/04/2009 | US20090142269 Isotoypically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins |
| 06/04/2009 | CA2707115A1 Chiral 2-(benzylsulfinyl)-thiazole derivatives and 2-[(1h-pyrazol-4-ylmethyl)sulfinyl]-thiazole derivatives, method for the production thereof, and use of same as herbicides and plant growth regulators |
| 06/03/2009 | EP2065374A1 2-(benzyl- and 1H-pyrazol-4-ylmethyl)sulfinyl-thiazol-derivatives as herbicides and plant growth regulators |
| 06/03/2009 | EP2065370A1 2-cyanobenzene sulfonamides as pesticides |
| 06/03/2009 | EP2064207A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 06/03/2009 | EP1786790B1 Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
| 06/03/2009 | EP1613319B1 Substituted phenyl acetamides and their use as protease inhibitors |
| 06/03/2009 | CN101448801A 5-phenyl-thiaz0l-2-YL-urea derivatives and use as PI3 kinase inhibitors |
| 06/03/2009 | CN101448800A Novel compounds as cannabinoid receptor ligands and uses thereof |
| 06/03/2009 | CN101445493A Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors |
| 06/03/2009 | CN101445492A Amide thiazole derivant, preparation method and use thereof |
| 06/03/2009 | CN101445491A Thiazolinone derivative and preparation method and application thereof |
| 06/03/2009 | CN100494177C Bi-amido heterocyclic derivative with antitumour activity and its preparation method and use |
| 06/03/2009 | CN100494176C Method for extracting alkali metals or calcium salt of halogen or haloalkyl substituted 2-hydroxy pyridine, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
| 06/02/2009 | US7541475 Substituted thiazoles |
| 06/02/2009 | US7541474 Catalyzed process of making C-5-substituted heterocyclic inhibitors of 11β-hydroxy steroid dehydrogenase type 1 |
| 06/02/2009 | US7541472 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides |
| 06/02/2009 | US7541381 Sulfur compounds such as 3-((4-chloroanilino)sulfonyl)thio-phene-2-carboxylic acid, used as enzymes inhibitors for prophylaxis of antibiotic resistant bacterial infections |
| 06/02/2009 | US7541373 2-[3-(2-cyclopentanecarbonyl-4-methyl-phenyl)-ureido]-thiazol-4-yl} acetic acid; 2-[3-(4-Methyl-2-[2-methylpropoxy] phenyl)-ureido]-thiazol-4-yl}-acetic acid; activators of glucokinase; treatment of metabolic disorders, hyperglycemic agent, syndrome x, anticholesterol, hypertension etc. |
| 06/02/2009 | CA2420297C Continuous process for the preparation of pesticidal chlorothiazoles |
| 06/02/2009 | CA2375625C Process for production of substituted 1-(2-benzothiazolyl) alkylamine derivative |
| 06/02/2009 | CA2350425C Use of an insulin sensitiser for the treatment of type 2 diabetes mellitus |
| 05/28/2009 | WO2009067697A1 Therapeutic compounds |
| 05/28/2009 | WO2009067618A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | WO2009067604A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 05/28/2009 | WO2009066790A1 N-cycl0alkylmethyl-2-amin0thiaz0le-5-carb0xamides for use in plant disease control |
| 05/28/2009 | WO2009065797A1 Process for obtaining mixtures of 4-carboxy-1,3-thiazolidinium carboxylate and n-acyl-1,3-thiazolidin-4-carboxylic acid |
| 05/28/2009 | WO2009049180A3 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 05/28/2009 | WO2009030467A3 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
| 05/28/2009 | US20090137817 Spatially-defined macrocyclic compounds useful for drug discovery |
| 05/28/2009 | US20090137642 2-Acylaminothiazole Derivatives |
| 05/28/2009 | US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives |
| 05/28/2009 | US20090137596 G-protein inhibitor |
| 05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
| 05/28/2009 | US20090137420 Methods, compounds and compositions with genotype selective anticancer activity |
| 05/28/2009 | US20090136979 Class IIA Histone Deacetylase (HDAC) Substrate |
| 05/28/2009 | US20090136472 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 05/28/2009 | CA2722591A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | CA2722586A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 05/28/2009 | CA2706586A1 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 05/28/2009 | CA2705878A1 N-cycl0alkylmethyl-2-amin0thiazole-5-carb0xamides for use in plant disease control |
| 05/27/2009 | EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP0934287B1 Heterocyclic esters and amides |
| 05/27/2009 | CN101443320A Bezothiazol derivatives as beta2 adrenoreceptor agonists |
| 05/27/2009 | CN101440071A 4,4'-bis[5,6- dichloro-2-benzothiazolylazoamino] biphenyl-3,3'-disulfonic acid, preparation and use thereof |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491361C Thiazole derivatives and their use as VAP-1 inhibitors |
| 05/27/2009 | CN100491356C Compounds exhibiting thrombopoietin receptor agaonism |
| 05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
| 05/27/2009 | CN100491323C Biaryloxymethylarenecarboxylic acids compound |
| 05/26/2009 | US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 05/26/2009 | US7538229 The present disclosure is directed to a process for the preparation of a compound having the formula:pesticidal activity. Generally, the process includes reacting a water-removing reagent, with a compound having the formula |
| 05/26/2009 | US7538228 Transition metal complexes of ligands, e.g., oxzolines, bis-oxazolines, phosphine oxazolines and analgous thiazolines, imidazolines, pyrazolines; conformational rigidity for high enantioselectivity using bidentate ligands; catalyzed reactions include hydrogenation, hydrosilation, hydroboration and others |
| 05/26/2009 | US7538125 Pioglitazone insulin sensitivity enhancer with the antidiabetic glimepiride; difference in mechanism of action avoids adverse reactions over long term use; oral dosage tablet; lactose excipient, hydroxypropylcellulose binder, magnesium stearate lubricant, calcium carbonate disintegrator; diabetes |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
| 05/22/2009 | WO2009064251A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/22/2009 | WO2009064250A1 Bis-(sulfonylamino) derivatives in therapy 065 |
| 05/22/2009 | WO2008043567A8 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 05/22/2009 | CA2705755A1 Bis-(sulfonylamino) derivatives in therapy 066 |
| 05/21/2009 | US20090131655 Cephem Compounds Having Broad Antibacterial Spectrum |
| 05/21/2009 | US20090131501 Alzheimer's disease; administering orally (+) phenserine; phenserine tartrate; racemic or enantiomerically pure; not toxic in a wide range of dosages |
| 05/21/2009 | US20090131475 Compositions and methods for the treatment of metabolic disorders |
| 05/21/2009 | US20090131468 Bis-(Sulfonylamino) Derivatives in Therapy 065 |
| 05/21/2009 | US20090131439 Therapeutic agent for chronic obstructive pulmonary disease |
| 05/21/2009 | US20090131428 Benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/21/2009 | US20090131384 Compounds and methods for treatment of disorders associated with er stress |
| 05/21/2009 | US20090130077 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 05/20/2009 | EP2059507A2 Ep2 agonists |
| 05/20/2009 | EP2003116A9 Process for the production of organic oxides |
| 05/20/2009 | EP1773348A4 Tetrapeptide analogs |
| 05/20/2009 | CN101434585A Amide derivatives as GK activators |
| 05/20/2009 | CN100488923C Double-loop coil organic compounds and electric-field luminescent devices |
| 05/20/2009 | CN100488506C 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 05/19/2009 | US7534887 Thiazoline derivative and use of the same |
| 05/19/2009 | US7534790 Aminocyclohexyl ether compounds such as trans-[2-(4-morpholinyl)-1-(2-naphthenethoxy)]cyclohexane; arrhythmia, analgesia and local anesthesia |
| 05/19/2009 | US7534475 For preparation of thin phase retarder, such as wide-ranged polarization plate, which gives inverse wavelength distribution |
| 05/19/2009 | CA2382406C Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 05/19/2009 | CA2375017C Hydrochloride of fused-heterocycle compound |
| 05/19/2009 | CA2211381C Compounds with growth hormone releasing properties |
| 05/14/2009 | WO2009061652A1 Compounds which modulate the cb2 receptor |
| 05/14/2009 | WO2009061233A1 Electroluminescent material containing an organic luminescent substance |
| 05/14/2009 | WO2009036000A3 Methods of treating a microbial infection by modulating rnase-l expression and/or activity |
| 05/14/2009 | US20090124809 Process for preparing acyclic hcv protease inhibitors |
| 05/14/2009 | US20090124808 Process for preparing acyclic hcv protease inhibitors |
| 05/14/2009 | US20090124676 Substituted cyclopentanes having prostaglandin activity |
| 05/14/2009 | US20090124675 Inhibitors of anti-apoptotic proteins |
| 05/14/2009 | US20090124674 Method for treating congestive heart failure |